This study is not accepting new patients

Expanded Access:18F-Fluorocholine for the Detection of Parathyroid Adenomas

a study on Parathyroid Adenomas

Summary

Eligibility
for people ages 13 years and up (full criteria)
Dates
study started
Principal Investigator
by Thomas Hope, MD (ucsf)
Headshot of Thomas Hope
Thomas Hope

Description

Summary

This expanded access protocol is proposed to allow University of California San Francisco (UCSF) patients additional access to 18F-fluorocholine (FCH) Positron Emission Tomography (PET) imaging for localization of parathyroid adenomas.

Details

No health outcome measures will be obtained under this protocol.

Keywords

Parathyroid Adenomas, Parathyroid Neoplasms, fluorocholine, Magnetic Resonance Spectroscopy, 18F-Fluorocholine (FCH), Positron emission tomography (PET)

Eligibility

You can join if…

Open to people ages 13 years and up

  1. Age ≥ 13 years.
  2. Evidence of primary hyperparathyroidism.
  3. Ability to understand a written informed consent document, and the willingness to sign it.

You CAN'T join if...

  1. Unlikely to comply with protocol procedures, restrictions and requirements and judged by the Investigator to be unsuitable for participation.

Lead Scientist at University of California Health

  • Thomas Hope, MD (ucsf)
    Thomas Hope, MD, is the Vice Chair of Clinical Operations and Strategy in the Department of Radiology. He also serves as the Director of Molecular Therapy. He serves as Chief of Nuclear Medicine at the San Francisco VA Medical Center and as chair of the Cancer Center’s Molecular Imaging & Radionuclide Therapy Site Committee.

Details

Status
not accepting new patients
Start Date
Sponsor
Thomas Hope
ID
NCT07218224
Study Type
Expanded Access
Last Updated